Please note that the standard 14-day cancellation right terminates upon receiving access to the e-book.
Product description
Pharmaceutical giants have been doubling their investments in drug development, only to see new drug approvals to remain constant for the past decade. This book investigates and highlights a set of proactive strategies, aimed at generating sustainable competitive advantage for its protagonists based on value-generating business practices. We focus on three sources of pharmaceutical innovation: new management methods in the drug development pipeline, new technologies as enablers for cutting-edge R&D, and new forms of internationalisation, such as outside-in innovation in the early phases of R&D.
Details
- ISBN13 9783319668338
- Released 2018
- Publisher Springer
- Format Elektronisk medie
- Edition 3
- Language English